Changjing Zuo

2.8k total citations · 1 hit paper
137 papers, 2.1k citations indexed

About

Changjing Zuo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Changjing Zuo has authored 137 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 47 papers in Pulmonary and Respiratory Medicine and 35 papers in Surgery. Recurrent topics in Changjing Zuo's work include Peptidase Inhibition and Analysis (23 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Radiomics and Machine Learning in Medical Imaging (17 papers). Changjing Zuo is often cited by papers focused on Peptidase Inhibition and Analysis (23 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Radiomics and Machine Learning in Medical Imaging (17 papers). Changjing Zuo collaborates with scholars based in China, United States and Singapore. Changjing Zuo's co-authors include Chao Cheng, Wenbo Bu, Dalong Ni, Jianlin Shi, Chen Zhang, Aisheng Dong, Qingfeng Xiao, Jianan Liu, Yanyan Liu and Yong Sun and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Changjing Zuo

129 papers receiving 2.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypoxia Induced by Upconversion‐Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors

2015 404 citations Yanyan Liu, Yong Liu et al. Angewandte Chemie International Edition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Changjing Zuo China	23	845	570	485	457	399	137	2.1k
Takahito Nakajima Japan	31	1.1k 1.3×	371 0.7×	987 2.0×	379 0.8×	316 0.8×	132	2.7k
Chao Cheng China	19	689 0.8×	487 0.9×	291 0.6×	293 0.6×	193 0.5×	61	1.4k
Wendy Kelder Netherlands	15	902 1.1×	213 0.4×	471 1.0×	548 1.2×	387 1.0×	31	2.2k
Zhide Guo China	26	1.2k 1.4×	600 1.1×	310 0.6×	787 1.7×	275 0.7×	99	2.8k
Jason M. Warram United States	32	1.8k 2.1×	363 0.6×	767 1.6×	549 1.2×	413 1.0×	91	3.2k
Yoshitomo Ashitate United States	24	1.4k 1.7×	569 1.0×	662 1.4×	261 0.6×	480 1.2×	42	2.7k
Niels J. Harlaar Netherlands	12	1.2k 1.4×	226 0.4×	567 1.2×	511 1.1×	562 1.4×	23	2.4k
Hui‐Xiong Xu China	30	2.0k 2.4×	742 1.3×	569 1.2×	278 0.6×	510 1.3×	52	3.2k
Yongkang Gai China	25	679 0.8×	278 0.5×	213 0.4×	508 1.1×	203 0.5×	96	1.8k
Johannes S. de Jong Netherlands	13	966 1.1×	216 0.4×	613 1.3×	626 1.4×	435 1.1×	14	2.5k

Countries citing papers authored by Changjing Zuo

Since Specialization

Citations

This map shows the geographic impact of Changjing Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjing Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjing Zuo more than expected).

Fields of papers citing papers by Changjing Zuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changjing Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjing Zuo. The network helps show where Changjing Zuo may publish in the future.

Co-authorship network of co-authors of Changjing Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Changjing Zuo. A scholar is included among the top collaborators of Changjing Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changjing Zuo. Changjing Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Xiaojing, Shengju Wu, Chunfu Zhang, et al.. (2025). A simple polydopamine‐based platform for engineering extracellular vesicles with brain‐targeting peptide and imaging probes to improve stroke outcome. Journal of Extracellular Vesicles. 14(1). e70031–e70031. 11 indexed citations

Ruan, Dan, Chengkun Han, Liang Zhao, et al.. (2024). ⁶⁸Ga-FAPI-46 PET/CT in the evaluation of gliomas: comparison with ¹⁸F-FDG PET/CT and contrast-enhanced MRI. Theranostics. 14(18). 6935–6946. 4 indexed citations

Wang, Yi‐Ting, Yuchao Li, Hongyuan Jiang, Changjing Zuo, & Wengui Xu. (2023). Elevated splenic 18F-fluorodeoxyglucose positron emission tomography/computed tomography activity is associated with 5-year risk of recurrence in non-metastatic invasive ductal carcinoma of the breast. British Journal of Radiology. 97(1153). 237–248. 1 indexed citations

Li, Danni, Guorong Jia, Xiaohong Li, et al.. (2023). Silk fibroin-based embolic agent for transhepatic artery embolization with multiple therapeutic potentials. Journal of Nanobiotechnology. 21(1). 278–278. 10 indexed citations

Cheng, Chao, et al.. (2023). SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis. Pharmaceuticals. 16(3). 423–423. 7 indexed citations

Yang, Mengdie, Haipeng Liu, Jiajia Zhang, et al.. (2023). Alpha‐Emitter Radium‐223 Induces STING‐Dependent Pyroptosis to Trigger Robust Antitumor Immunity. Small. 20(9). e2307448–e2307448. 14 indexed citations

Wo, Da, Jingxiao Chen, Xiaohui Zhou, et al.. (2023). Inhibition of a novel Dickkopf-1-LDL receptor–related proteins 5 and 6 axis prevents diabetic cardiomyopathy in mice. European Heart Journal. 45(9). 688–703. 8 indexed citations

Wang, Fei, Chao Cheng, Shengnan Ren, et al.. (2022). Prognostic Evaluation Based on Dual-Time 18F-FDG PET/CT Radiomics Features in Patients with Locally Advanced Pancreatic Cancer Treated by Stereotactic Body Radiation Therapy. Journal of Oncology. 2022. 1–9. 3 indexed citations

Li, Danni, Liyan Xiong, Guixia Pan, et al.. (2022). Molecular imaging on ACE2‐dependent transocular infection of coronavirus. Journal of Medical Virology. 94(10). 4878–4889. 9 indexed citations

10.

Jia, Guorong, et al.. (2021). Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 14(2). e1749–e1749. 34 indexed citations

11.

Liu, Zhaobang, Changjing Zuo, Zehong Yang, et al.. (2021). Radiomics model of dual-time 2-[18F]FDG PET/CT imaging to distinguish between pancreatic ductal adenocarcinoma and autoimmune pancreatitis. European Radiology. 31(9). 6983–6991. 36 indexed citations

12.

Yao, Minghua, Xiaojing Shi, Changjing Zuo, et al.. (2020). Engineering of SPECT/Photoacoustic Imaging/Antioxidative Stress Triple-Function Nanoprobe for Advanced Mesenchymal Stem Cell Therapy of Cerebral Ischemia. ACS Applied Materials & Interfaces. 12(34). 37885–37895. 44 indexed citations

13.

Cheng, Chao, et al.. (2019). Predictive value of 18F-FDG PET/CT related metabolic parameters for Kras mutation in colorectal cancer patients. 39(2). 86–90. 2 indexed citations

14.

Pan, Guixia, Danni Li, Xiao Li, et al.. (2018). SPECT/CT imaging of HER2 expression in colon cancer-bearing nude mice using 125I-Herceptin. Biochemical and Biophysical Research Communications. 504(4). 765–770. 4 indexed citations

15.

Wang, Tao, Guorong Jia, Chao Cheng, et al.. (2018). Active targeted dual-modal CT/MR imaging of VX2 tumors using PEGylated BaGdF₅ nanoparticles conjugated with RGD. New Journal of Chemistry. 42(14). 11565–11572. 9 indexed citations

16.

Liu, Yanyan, Xianfu Meng, Han Wang, et al.. (2017). Photoelectron Transfer at ZnTPyP Self-Assembly/TiO₂ Interfaces for Enhanced Two-Photon Photodynamic Therapy. ACS Applied Materials & Interfaces. 10(2). 1492–1498. 17 indexed citations

17.

Liu, Yanyan, Yong Liu, Wenbo Bu, et al.. (2015). Hypoxia Induced by Upconversion‐Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors. Angewandte Chemie International Edition. 54(28). 8105–8109. 404 indexed citations breakdown →

18.

Dong, Aisheng, Changjing Zuo, Jianping Lu, & Yang Wang. (2013). MRI, Enhanced CT, and FDG PET/CT in Basal Cell Carcinoma of the Prostate. Clinical Nuclear Medicine. 39(8). 721–724. 2 indexed citations

19.

Sun, Gaofeng, Jianhua Wang, Jian Zhang, et al.. (2013). High-resolution magic angle spinning 1H magnetic resonance spectroscopy detects choline as a biomarker in a swine obstructive chronic pancreatitis model at an early stage. Molecular BioSystems. 10(3). 467–474. 13 indexed citations

20.

Wang, Jianhua, Xiaolong Ma, Fangyuan Ren, et al.. (2012). Multi-modality imaging findings of splenic hamartoma: a report of nine cases and review of the literature. Abdominal Imaging. 38(1). 154–162. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact